Covered recipient · General Payments record
LAURA BRINKLEY
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2024
$327.20
- Reported across 16 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $327.20 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $76.10 | 4 |
| Lilly USA, LLC | $69.81 | 4 |
| Exact Sciences Corporation | $51.03 | 2 |
| Merck Sharp & Dohme Corporation | $49.24 | 2 |
| EISAI INC. | $24.54 | 1 |
| GlaxoSmithKline, LLC. | $21.69 | 1 |
| Novo Nordisk AS | $20.81 | 1 |
| Nevro Corp. | $13.98 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $327.20 | 16 |
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Eisai Inc. | $24.54 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110810924 | CMS |
| Exact Sciences Corporation | $23.23 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114599241 | CMS |
| Exact Sciences Corporation | $27.80 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114599246 | CMS |
| GlaxoSmithKline, LLC. | $21.69 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116494082 | CMS |
| Lilly USA, LLC | $15.23 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135807383 | CMS |
| Lilly USA, LLC | $16.46 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135782466 | CMS |
| Lilly USA, LLC | $18.09 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135790402 | CMS |
| Lilly USA, LLC | $20.03 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135790404 | CMS |
| Merck Sharp & Dohme LLC | $27.36 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141960018 | CMS |
| Merck Sharp & Dohme LLC | $21.88 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141970423 | CMS |
| Nevro Corp. | $13.98 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130779597 | CMS |
| Novo Nordisk Inc | $20.81 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100560755 | CMS |
| PFIZER INC. | $13.15 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131452344 | CMS |
| PFIZER INC. | $17.78 | 08/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131539303 | CMS |
| PFIZER INC. | $25.49 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131541322 | CMS |
| PFIZER INC. | $19.68 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131495381 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.